Overview
Prostate imaging includes MRI ultrasound and nuclear techniques for detection and staging. Multiparametric MRI is central to lesion detection and biopsy guidance. Imaging supports treatment planning and surveillance.
Multiparametric MRI
mpMRI combines T2 diffusion and perfusion sequences for lesion characterization. It improves detection of clinically significant cancer and guides targeted biopsy. Standardized reporting systems aid communication.
PET Tracers
Prostate specific membrane antigen PET improves detection of recurrent and metastatic disease. PSMA PET complements MRI and conventional imaging in staging. Tracer availability and interpretation expertise influence use.
Biopsy Guidance
MRI ultrasound fusion and targeted biopsy improve diagnostic yield. Imaging guided biopsy reduces sampling error and overdiagnosis. Coordination with urology ensures appropriate management.